PubMed Health⌕ Search

Biomedical subjects

Naomi Ijichi

Publications and source records attributed to Naomi Ijichi.

7 recordsLinked to original sources
PubMed2006

Computerized lifelong mentoring support using robot for autistic individuals.

Developmental diversity in childhood is transformed into personality variation in adulthood. This view is now revalued through an ongoing paradigm shift in the field of developmental conditions, the transition from the qualitative dichotomy perspective to the quantitative concept. In the quantitative concept, autism is not a disease nor a developmental qualitative disorder, but a behavioral extreme in individual variation. Although the traditional qualitative view cannot interpret the recent worldwide prevalence of autism, the increase in the reported number of cases with autism and border cases can be easily explained by a dimensional exploration in which the primary autistic phenotype is regarded as an evolutional superiority. Therefore, the only suitable intervention is mentoring which provides a powerful lifelong support for higher social achievement in individuals with autism. Here, we hypothesize the coming mentoring circumstances for autistic individuals in the near future. Ongoing progress in robot and computer technology might allow the guardians to leave the major part of mentoring support to an individualized robot, and the 'folk physics' tendency in individuals with autism could facilitate the spread of the mentoring support system. The development of the robot mentor software may be simple because of the uniformity and stereotypy of the behavior patterns in individuals with autism. With the help of the robot mentor and under its guidance, autistic people might enjoy their social life and contribute to the prosperity of the human society to the maximum degree. Because the future population ratio of autistics/non-autistics might be reversed according to the current trend of the prevalence, mentoring robot programs for autistic individuals should be developed without delay as a novel preliminary activity in the Jiminy Cricket movement, which is a campaign to reverse the estrangement of the present majority from autism and to increase the number of mentors for autistic individuals. In this article, prerequisites for the mentoring program of the robot mentor are expected and discussed.

Adult↗
PubMed2004

The prenatal autistic imprinting hypothesis: developmental maladaptation to the environmental changes between womb and the social world.

Although the importance of biological and genetic aspects of the etiology is well recognized, the pathological process of autism still remains to be elucidated. In contrast to a qualitative dichotomy concept, a dimensional perspective that places the autistic traits as quantitative extremes can easily explain the diversity and subtlety of the clinical features. In a dimensional (quantitative continuum) condition, no single qualitative process can distinguish the extremes from normal variations. In addition, the traditional view, which regards autism as a hypo-reproductive disease with a strong genetic contribution, cannot interpret the recent worldwide prevalence of autism. From a novel viewpoint, we have proposed 'the prenatal autistic imprinting hypothesis' in which autism is regarded as an inevitable consequence of human social evolution in both past and future. Postulated primary phenotypes are closely associated with the autistic savant skills and the autistic adherent temperament, and might increase the chance of specific prenatal experiences, named 'autistic imprinting'. An earlier prenatal brain growth and an earlier establishment of a type of consciousness may be critical for the imprinting process. A postnatal autistic social maladaptation may be a mere outcome of the putative intrauterine behavioral adaptation in individuals with the primary phenotypes. Both an autistic manner of thinking, which is referred to as 'visual thinking', and the prenatal early development of visual cortical architectures may play a key role in the autistic imprinting process.

Adaptation, Physiological↗
PubMed2003

The scientific establishment of a new therapeutic intervention for developmental conditions: practical and ethical principles.

BACKGROUND: Although the randomized controlled trial (RCT) is a major methodological breakthrough extending the limits of objectivity in clinical medical science, clinical trials of surgery have seldom included placebo surgery as a control, for ethical reasons. Especially in clinical studies intended eventually to establish a new intervention for developmental conditions, it has been recognized that there is huge examiner bias. In addition, the many miraculous cases that have been reported in nonsurgical open trials for developmental conditions and have eventually been evaluated as nonspecific positive outcomes in RCTs suggest that empirically promising interventions must be subjected to scientific scrutiny as soon as possible in the field of developmental conditions. APPLICATION TO PEDIATRIC NEUROSURGERY: Therefore, in childhood neurosurgery, clinical studies to establish a new therapeutic measure for developmental conditions should be designed as rigorously as possible using optimized scientific methods. The worldwide ethical guideline, the Declaration of Helsinki issued by the World Medical Association, can provide principles for the establishment of a new intervention in the treatment of a patient when proven therapeutic methods do not exist or methods used thus far have been ineffective. Physicians' discretion to use unproven or new therapeutic measures for such patients is approved in the presence of efforts of an ethical and scientific approach. Even if the measure is a very promising intervention, the research aspects must completely be demonstrated for informed consent and review by the ethical committee and the trial must be regarded as a clinical research. Especially when an RCT is not possible for ethical reasons, appropriate epidemiological data or animal experiments should suggest that the new measure is effective before a clinical trial. In a clinical setting, where neither epidemiological studies nor animal experimentation can be introduced, if necessary the researcher should collaborate with experts to obtain multidisciplinary justification for clinical testing.

Animals↗